Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Medtronic Plc (NYSE: MDT) closed at $99.62 down -1.62% from its previous closing price of $101.26. In other words, the price has decreased by -$1.62 from its previous closing price. On the day, 4.66 million shares were traded. MDT stock price reached its highest trading level at $101.9999 during the session, while it also had its lowest trading level at $99.575.
Ratios:
For a deeper understanding of Medtronic Plc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.53. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.57.
On June 16, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $110.Leerink Partners initiated its Outperform rating on June 16, 2025, with a $110 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 19 ’25 when Smith Gregory L sold 30,000 shares for $101.95 per share. The transaction valued at 3,058,451 led to the insider holds 46,016 shares of the business.
Smith Gregory L bought 30,000 shares of MDT for $3,058,452 on Nov 19 ’25. On Sep 03 ’25, another insider, KIIL HARRY SKIP, who serves as the EVP & President Cardiovascular of the company, sold 8,605 shares for $91.58 each. As a result, the insider received 788,048 and left with 35,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDT now has a Market Capitalization of 127774212096 and an Enterprise Value of 150921953280. As of this moment, Medtronic’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.91, and their Forward P/E ratio for the next fiscal year is 16.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.67 while its Price-to-Book (P/B) ratio in mrq is 2.62. Its current Enterprise Value per Revenue stands at 4.342 whereas that against EBITDA is 15.765.
Stock Price History:
The Beta on a monthly basis for MDT is 0.72, which has changed by 0.22117698 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, MDT has reached a high of $106.33, while it has fallen to a 52-week low of $79.29. The 50-Day Moving Average of the stock is 2.87%, while the 200-Day Moving Average is calculated to be 9.61%.
Shares Statistics:
For the past three months, MDT has traded an average of 7.18M shares per day and 6307590 over the past ten days. A total of 1.28B shares are outstanding, with a floating share count of 1.28B. Insiders hold about 0.07% of the company’s shares, while institutions hold 88.43% stake in the company. Shares short for MDT as of 1763078400 were 13532095 with a Short Ratio of 1.89, compared to 1760486400 on 14948934. Therefore, it implies a Short% of Shares Outstanding of 13532095 and a Short% of Float of 1.06.
Dividends & Splits
According to the company, the forward annual dividend rate for MDT is 2.82, from 2.82 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0278491. The stock’s 5-year Average Dividend Yield is 2.87. The current Payout Ratio is 77.47% for MDT, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-12-26. Stock splits for the company last occurred on 1999-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
A comprehensive evaluation of Medtronic Plc (MDT) is underway, with the input of 26.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $1.69, with high estimates of $1.71 and low estimates of $1.65.
Analysts are recommending an EPS of between $6.0 and $5.58 for the fiscal current year, implying an average EPS of $5.65. EPS for the following year is $6.11, with 30.0 analysts recommending between $6.25 and $5.98.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $8.89B this quarter.It ranges from a high estimate of $8.96B to a low estimate of $8.71B. As of. The current estimate, Medtronic Plc’s year-ago sales were $8.29BFor the next quarter, 17 analysts are estimating revenue of $9.63B. There is a high estimate of $9.68B for the next quarter, whereas the lowest estimate is $9.38B.
A total of 17 analysts have provided revenue estimates for MDT’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.96B, resulting in an average revenue estimate of $36.06B. In the same quarter a year ago, actual revenue was $33.54BBased on 17 analysts’ estimates, the company’s revenue will be $38.14B in the next fiscal year. The high estimate is $38.77B and the low estimate is $37.82B.
